Expertise

Strong Pharma Background in industry-leading cheminformatics and compound analysis. We help clients progress early stage discovery activities, working collaboratively to implement in silico drug design techniques, maximizing the potential of compounds to reach later development stages.

Our expertise covers:

Compound collection analyses and library design

Structure-activity relationships

Multiparameter compound optimization

Compound progressibility analyses

Capabilities

Our success relies on secure professional collaboration, solid experience in pharmaceutical research and the most up-to-date computational tools.

A variety of applications are available covering Pharma and non-Pharma research. Our expertise ranges from industry leading commercially licensed molecular modelling suites, to open source workflow systems and relational databases.

Collaboration work continues and now includes small biotechs, EU & US pharma, EU chemistry providers & EU screening centers

Q2 2017

Collaboration work continues and now includes small biotechs, EU & US pharma, EU chemistry providers & EU screening centers

Q1 2017

The 3D-e-Chem consortium, a team of chem- and bioinformatics researchers [CMBI (Radboudumc), Netherlands eScience Center, BioAxis Research, and Vrije Universiteit Amsterdam] have developed an open source virtual machine for computer-aided drug design. Described in a recent publication, the computational building blocks (nodes) that enable researchers to design their own drug discovery workflows are now incorporated in KNIME, the leading open data analytics platform.